Eleven Brand/Generic Drug Patent Settlements Reported To FTC Since January
This article was originally published in The Pink Sheet Daily
Executive Summary
None of those settlements involved “reverse payments,” FTC staff attorney Kades says. In total, 17 agreements have been reported to FTC since January.